High affinity acylating antagonists for muscarinic receptors

• Published in: Life sciences (1973) Vol. 51; no. 5; p. 345
• Main Authors: Baumgold, J, Karton, Y, Malka, N, Jacobson, K A
• Format: Journal Article
• Language: English
• Published: Netherlands 1992
• Subjects: Acylation; Affinity Labels - chemical synthesis; Affinity Labels - pharmacology; Animals; Cross-Linking Reagents; Dose-Response Relationship, Drug; Heart - drug effects; In Vitro Techniques; Isothiocyanates; Male; Muscarinic Antagonists; Parasympatholytics - chemical synthesis; Parasympatholytics - pharmacology; Pirenzepine - analogs & derivatives; Pirenzepine - chemical synthesis; Pirenzepine - pharmacology; Prosencephalon - drug effects; Rats; Thiocyanates
• ISSN: 0024-3205
• DOI: 10.1016/0024-3205(92)90586-E

The muscarinic antagonists pirenzepine and telenzepine were derivatized as alkylamino derivatives at a site on the molecules corresponding to a region of bulk tolerance in receptor binding. The distal primary amino groups were coupled to the cross-linking reagent meta-phenylene diisothiocyanate, resulting in two isothiocyanate derivatives that were found to inhibit muscarinic receptors irreversibly and in a dose-dependent fashion. Preincubation of rat forebrain membranes with an isothiocyanate derivative followed by radioligand binding using [3H]N-methylscopolamine diminished the Bmax value, but did not affect the Kd value. The receptor binding site was not restored upon repeated washing, indicating that irreversible inhibition had occurred. IC50 values for the irreversible inhibition at rat forebrain muscarinic receptors were 0.15 nM and 0.19 nM, for derivatives of pirenzepine and telenzepine, respectively. The isothiocyanate derivative of pirenzepine was non-selective as an irreversible muscarinic inhibitor, and the corresponding derivative prepared from telenzepine was 5-fold selective for forebrain (mainly m1) vs. heart (m2) muscarinic receptors.